Hematological Disorders in Patients With GI Angiodysplasia
ConditionGI Bleeding
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
The aim of this study will be to assess the association between GIT angiodysplasia with any hematological disorders as von Willebrand factor and Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All patients eligible to participate will undergo the following: 1. upper endoscopy 2. Colonoscopy 3. Complete blood count, CRP 4. D-Dimer, liver function tests, blood Urea and serum Creatinine 5. ECG 6. Coagulation profile (aPTT , von Willebrand factor activity \&antigen)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Correlation between GIT Angiodysplasia and Hematological disorders
All patients eligible to participate will undergo the following: 1. upper endoscopy 2. Colonoscopy 3. Complete blood count, CRP 4. D-Dimer, liver function tests, blood Urea and serum Creatinine 5. ECG 6. Coagulation profile (aPTT , von Willebrand factor activity \&antigen)
Time frame
BaselineSecondary outcomes
1
Prevelance of different hematological disorders in angiodysplasia patients
Time frame
Baseline2
Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: